Stroke Clinical Trials

Find Stroke Clinical Trials Near You

Effect of Cerebrolysin on Early Rehabilitation After Ischemic Stroke at the Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT), University Medical Centre Ljubljana

Status: Recruiting
Location: See location...
Intervention Type: Other, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Being able to perform ARAT test Signed informed consent

• Both sexes, age not specified

• Acute ischemic stroke confirmed by imaging

• NIHSS score 6-12

• No prior stroke or disability (mRS 0 before stroke)

• \-

Locations
Other Locations
Slovenia
UMC Ljubljana - Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT)
RECRUITING
Ljubljana
Contact Information
Primary
Matija Zupan, MD, PhD
matija.zupan@kclj.si
0038615229581
Backup
Marjan Zaletel, MD, PhD
marjan.zaletel@kclj.si
0038615227115
Time Frame
Start Date: 2025-06-13
Estimated Completion Date: 2027-10-15
Participants
Target number of participants: 30
Treatments
Experimental: Arm 1: Cerebrolysin Group
The patients in Arm 1 will be treated with cerebrolysin and standard treatment.
Other: Arm 2: Standard treatment only Group
The patients in Arm 2 will receive standard treatment only.
Related Therapeutic Areas
Sponsors
Leads: University Medical Centre Ljubljana

This content was sourced from clinicaltrials.gov